$1.93
-0.11[-5.39%]
At close: Apr 19
$1.93
0[0.00%]
After Hours: 7:49PM EDT
Acurx Pharmaceuticals
(NASDAQ:ACXP)Latest News for Acurx Pharmaceuticals Stock (NASDAQ:ACXP)
Acurx Pharmaceuticals Stock (NASDAQ: ACXP)
Categories: All
Thursday, April 18, 2024
Tuesday, March 19, 2024
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Mar 19, 2024, 1:31PM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Mar 19, 2024, 9:05AM
- Acurx Pharmaceuticals shares are trading lower after the company filed for a common stock offering.Benzinga Newsdesk - Mar 19, 2024, 7:04AM
- HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $12Benzinga Newsdesk - Mar 19, 2024, 6:32AM
Monday, March 18, 2024
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Mar 18, 2024, 5:33PM
- Acurx Pharmaceuticals shares are trading lower after the company filed for a common stock offering.Benzinga Newsdesk - Mar 18, 2024, 4:35PM
- Acurx Pharmaceuticals Inc Files For Common Stock Offering; Size Not DisclosedBenzinga Newsdesk - Mar 18, 2024, 4:08PM
- Acurx Pharmaceuticals Q4 EPS $(0.37) Misses $(0.26) EstimateBenzinga Newsdesk - Mar 18, 2024, 7:04AM
- Earnings Scheduled For March 18, 2024Benzinga Insights - Mar 18, 2024, 5:57AM
Friday, March 15, 2024
Wednesday, February 28, 2024
Tuesday, February 27, 2024
- Acurx Announces FDA Has Granted An End Of Phase 2 Meeting For Ibezapolstat For C. Difficile Infection And The European Medicines Agency Granted SME Designation For Ibezapolstat EU DevelopmentBenzinga Newsdesk - Feb 27, 2024, 7:11AM
- Acurx Announces FDA Has Granted An End Of Phase 2 Meeting For Ibezapolstat For C. difficile Infection And European Medicines Agency Granted SME Designation For Ibezapolstat EU DevelopmentBenzinga Newsdesk - Feb 27, 2024, 7:10AM
Monday, January 29, 2024
- Acurx Reports Extended Clinical Cure Data For Ibezapolstat, Its Lead Antibiotic Candidate, From Recently Completed Phase 2B Clinical Trial In Patients With CDIBenzinga Newsdesk - Jan 29, 2024, 7:06AM
- Acurx Announces Extended Clinical Cure Data For Ibezapolstat From Phase 2b Clinical Trial In CDI Patients; 5 Of 5 Ibezapolstat-Treated Patients Who Agreed To Observation For Up To Three Months Following Clinical Cure Of Cdi Experienced No Recurrence Of InfectionBenzinga Newsdesk - Jan 29, 2024, 7:02AM
Wednesday, January 17, 2024
- Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Jan 17, 2024, 1:12PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jan 17, 2024, 12:31PM
- Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?Vandana Singh - Jan 17, 2024, 11:26AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jan 17, 2024, 8:05AM
- Acurx Pharmaceuticals Announced Comparative Microbiology And Microbiome Data For Ibezapolstat, Its Lead Antibiotic Candidate, From Phase 2B Trial In Clostridioides Difficile Infection, Showing Ibezapolstat Outperformed Vancomycin, A Standard Of CareBenzinga Newsdesk - Jan 17, 2024, 7:06AM
Friday, December 15, 2023
Thursday, December 14, 2023
Monday, December 11, 2023
- Acurx's Antibiotic Shows All Patients With Clinical Cure Remained Infection-Free After End Of TreatmentVandana Singh - Dec 11, 2023, 10:50AM
- Acurx Announces Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical CureBenzinga Newsdesk - Dec 11, 2023, 7:03AM
Wednesday, November 15, 2023
Tuesday, November 14, 2023
Monday, November 06, 2023
- Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Nov 6, 2023, 1:36PM
- Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 6, 2023, 8:08AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Nov 6, 2023, 8:06AM
Friday, November 03, 2023
Thursday, November 02, 2023
- Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Nov 2, 2023, 2:26PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Nov 2, 2023, 1:31PM
- Acurx Pharmaceuticals Stock Is Plummeting After Biotech Publishes Phase 2 ResultsVandana Singh - Nov 2, 2023, 12:12PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Nov 2, 2023, 9:05AM
- Acurx Pharmaceuticals Shares Selloff After Co Announced Top-Line Ibezapolstat Phase 2 Efficacy Results In Patients With C. difficile InfectionCharles Gross - Nov 2, 2023, 7:44AM
- Acurx Pharmaceuticals Announced Efficacy Results From The Phase 2 Trial Of Ibezapolstat For C. Difficile Infection, With 96% Clinical Cure Rate In PatientsBenzinga Newsdesk - Nov 2, 2023, 7:44AM
Friday, October 27, 2023
Thursday, October 19, 2023
Wednesday, October 18, 2023
Monday, October 16, 2023
Thursday, October 12, 2023
- Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Oct 12, 2023, 12:55PM
- What's Going On With Acurx Pharmaceuticals Stock Now?Erica Kollmann - Oct 12, 2023, 12:47PM
- Acurx Pharmaceuticals Shares Resume TradingBenzinga Newsdesk - Oct 12, 2023, 12:15PM
- Acurx Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 128.6%Benzinga Newsdesk - Oct 12, 2023, 12:10PM
- Acurx Pharmaceuticals Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 98%Benzinga Newsdesk - Oct 12, 2023, 12:09PM